Comparison of Blood Glucose Measurement Values
Pain, Acute, Glucose Test Site Bleeding
About this trial
This is an interventional supportive care trial for Pain, Acute focused on measuring blood glucose measurements, intensive care patients, venous blood, capillary blood, arterial blood
Eligibility Criteria
Inclusion Criteria: patients who age bigger than18 patients who have capillary fullness is good patients who have a central venous catheter patients who have an arterial catheter Exclusion Criteria: patients who have predibatic will be excluded from the study. The research has been added to the exclusion criteria and has been changed both in the relevant field in the system and in the project application file. In the ADA (American Diabetes Association) definition of prediabetes, IGT (Impaired Glucose Tolerance) (140-200 mg/dl), lower IAG (Impaired Fasting Glucose) (100-125 mg/dl) and additional supplementation according to WHO (World Health Organization) It is based on the criteria of hemoglobin A1c (HbA1c: Hemoglobin A1c) between 5.7% and 6.4% (ADA,2014). Meeting one of the three criteria is defined as prediabetes. Prediabetes screening is performed using 75 g OGTT, HbA1C, FPG, or a 2-hour oral glucose challenge test. patients with Diabetes Mellitus, patients with coagulopathy patients who receive high-dose vasopressors, acetamifon, ascorbic acid, mannitol, corticosteroid, renal replacement therapy patients who do not agree to participate in the research, patients who have upper extremity amputation, cast, etc. (capillary blood sample cannot be taken for reasons)
Sites / Locations
Arms of the Study
Arm 1
Other
SINGLE GROUP
This is a quasi-experimental study with a single group and simultaneous (matched) sample will conduct with the purpose of to determine whether glucose values are different for a bedside glucose meter compared to the main clinical laboratory and whether the blood sampling site has a significant effect on glucose values.